Crescent Biopharma, Inc.
CBIO
$10.60
$0.252.42%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 59.98% | -12.70% | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 320.88% | -17.95% | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 75.87% | -12.75% | |||
|
|
|||||
| Total Current Assets | 75.87% | -12.75% | |||
| Net Property, Plant & Equipment | -1.32% | 30.33% | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -2.72% | -3.27% | |||
| Total Assets | 73.79% | -12.17% | |||
|
|
|||||
| Total Accounts Payable | 290.36% | 55.40% | |||
| Total Accrued Expenses | 8.18% | 19.13% | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 4.32% | 97.63% | |||
| Total Finance Division Other Current Liabilities | 338.51% | -0.38% | |||
| Total Other Current Liabilities | 338.51% | -0.38% | |||
| Total Current Liabilities | 77.66% | 21.25% | |||
|
|
|||||
| Total Current Liabilities | 77.66% | 21.25% | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -8.69% | -7.61% | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 72.37% | 18.97% | |||
|
|
|||||
| Common Stock & APIC | 93.08% | 1.05% | |||
| Retained Earnings | -116.35% | -44.90% | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | 76.68% | -16.72% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | 0.00% | 0.00% | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | 0.00% | 0.00% | |||
|
|
|||||
| Total Common Equity | 76.68% | -16.72% | |||
| Total Preferred Equity | 0.00% | 0.00% | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 74.05% | -16.24% | |||
|
|
|||||